Last updated: February 6, 2024
Sponsor: University of Alberta
Overall Status: Trial Not Available
Phase
N/A
Condition
Memory Loss
Amyotrophic Lateral Sclerosis (Als)
Scar Tissue
Treatment
N/AClinical Study ID
NCT05830214
Pro00125737
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
[PATIENTS] Inclusion Criteria:
- Has ALS, classified as definite, probable, laboratory-supported probable, or possibleALS according to the revised El Escorial criteria or a related neurodegenerativedisorder including ALS-FTD, PLS, PMA or asymptomatic individuals with a known ALSmutation (as previously confirmed during the individual's regular clinical care)
- Is the age of majority in their province of residence/treatment
- Has the cognitive capacity to provide informed consent
- Has proficiency in English or French in order to understand study instructions andrespond to questionnaires
Exclusion
Exclusion Criteria:
- Is pregnant
- Has a history of active (clinically significant) skin disorders
- Has a history of allergic response to plastic materials
- Has an electronic implant of any kind (e.g. pacemaker)
- Has broken, damaged or irritated skin or rashes near the sensor application sites
- Is unstably housed or lack reliable contact information.
- Investigator judges that device retrieval will be difficult or unlikely
- Does not have a smartphone that will support the HG application
- Does not have daily access to a wireless connection
[HEALTHY CONTROLS] Inclusion Criteria:
- Be between the ages of 40-80 unless age matched to a patient (+/-3 years) who isalready enrolled.
- Is the age of majority in their province of residence/treatment
- Has the cognitive capacity to provide informed consent
- Has proficiency in English or French in order to understand study instructions andrespond to questionnaires Exclusion Criteria:
- Has a history of a neurological disease, including Central Nervous System disease (e.g., stroke, head injury, epilepsy) or Peripheral Nervous System disease (neuropathy, myopathy).
- Has a history of psychiatric disease (e.g., depression, bipolar disease) that isclinically diagnosed and/or with the current use of psychiatric medications (e.g.,antidepressants) for an indication of a psychiatric disease.
- Is pregnant
- Has a history of active (clinically significant) skin disorders
- Has a history of allergic response to plastic materials
- Has an electronic implant of any kind (e.g. pacemaker)
- Has broken, damaged or irritated skin or rashes near the sensor application sites
- Is unstably housed or lack reliable contact information.
- Investigator judges that device retrieval will be difficult or unlikely
- Does not have a smartphone that will support the HG application
- Does not have daily access to a wireless connection
Study Design
Study Start date:
January 01, 2024
Estimated Completion Date:
February 06, 2024
Study Description
Connect with a study center
University of Alberta
Edmonton, Alberta T6G 2B7
CanadaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.